research use only
Cat.No.S8616
| Related Targets | Dehydrogenase HSP Transferase P450 (e.g. CYP17) PDE phosphatase PPAR Vitamin Carbohydrate Metabolism Mitochondrial Metabolism |
|---|---|
| Other PKM Inhibitors | Mitapivat (AG-348) (±)-Shikonin TEPP-46 (ML265) DASA-58 TP-1454 ZIP Alkannin DL-Serine |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| HCT116 | Antiproliferative assay | 48 hrs | Antiproliferative activity against human HCT116 cells after 48 hrs by MTS assay, IC50=0.18μM | 28688274 | ||
| HeLa | Antiproliferative assay | 48 hrs | Antiproliferative activity against human HeLa cells after 48 hrs by MTS assay, IC50=0.29μM | 28688274 | ||
| NCI-H1299 | Antiproliferative assay | 48 hrs | Antiproliferative activity against human NCI-H1299 cells after 48 hrs by MTS assay, IC50=1.56μM | 28688274 | ||
| NCI-H1299 | Antiproliferative assay | 48 hrs | Antiproliferative activity against human NCI-H1299 cells after 48 hrs in presence of PKM2 activator FBP by MTS assay, IC50=2.01μM | 28688274 | ||
| BEAS2B | Cytotoxicity assay | 48 hrs | Cytotoxicity against human BEAS2B cells assessed as reduction in cell viability after 48 hrs by MTS assay, IC50=18.46μM | 28688274 | ||
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
DMSO
: 6 mg/mL
(17.36 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 345.48 | Formula | C18H19NO2S2 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 94164-88-2 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | PKM2-IN-1 | Smiles | CC1=C(C(=O)C2=CC=CC=C2C1=O)CSC(=S)N3CCCCC3 | ||
| Targets/IC50/Ki |
PKM2
(Cell-free assay) 2.95 μM
|
|---|---|
| In vitro |
The well performing PKM2 inhibitor (compound 3k) shows nanomolar antiproliferative activity toward a series of cancer cell lines with high expression of PKM2 including HCT116, Hela and H1299 with IC50 values ranging from 0.18-1.56 μM. Moreover, it exhibits more cytotoxicity on cancer cells than normal cells. |
| In vivo |
Compound 3K (PKM2-IN-1) is an enzymatic inhibitor of pyruvate kinase M2 (PKM2). |
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.